Diamonds and Dogs

12/9/19

Cancer drugs and cancer drug companies in play today. ArQule (ARQL) is up 100% today after agreeing to merge with Merck for $2.7 billion. ArQule is working on treatments for cancer including a new drug for a range of blood cancers. French drug giant Sanofi also agreed to buy a firm, Synthorx for $2.5 billion. Synthorx is a maker of therapies that harness the immune system to fight tumors. Bristol Myers is up 2% to new highs on positive data on a lymphoma drug.

Datadog (DDOG) is a dog today. The cloud software tech firm is down 4% ahead of a lock up for insiders. Datadog came public in September. The stock performed well in November on new product launches, but 20% of their shares will be eligible for sale starting tomorrow. With a stock trading for 20 times sales and still losing money, there may be more pain ahead.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.